TERT promoter mutations and telomere length in adult malignant gliomas and recurrences. - Wikidata - awgldk - TriplyDB

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.

http://www.wikidata.org/entity/Q35833084

about

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene Genetic variations in the TERT and CLPTM1L gene region and gastrointestinal stromal tumors risk Molecular Testing of Brain Tumor.Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression BRAF Mutation is Associated with an Improved Survival in Glioma-a Systematic Review and Meta-analysis.TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas Association of peripheral leukocyte telomere length and its variation with pancreatic cancer and colorectal cancer risk in Chinese population.Association of TERT promoter mutations with telomerase expression in melanoma.Circulating tumor cell is a common property of brain glioma and promotes the monitoring system Frequent DPH3 promoter mutations in skin cancers.Telomere maintenance in soft tissue sarcomas High incidence of TERT mutation in brain tumor cell lines.Altered TERT promoter and other genomic regulatory elements: occurrence and impact.The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.Association of Telomerase Reverse Transcriptase Promoter Mutations with the Prognosis of Glioma Patients: a Meta-Analysis.Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy.Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss.Understanding the Molecular Genetics of Basal Cell Carcinoma.Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.Bleomycin-induced chromosomal damage and shortening of telomeres in peripheral blood lymphocytes of incident cancer patients.Telomere Maintenance Mechanisms in Cancer.Structural basis for reactivating the mutant TERT promoter by cooperative binding of p52 and ETS1

P2860

Q26738705-AF5C501E-17F9-45BE-942F-BAC071821CB8 Q26739925-6B97683D-6E0C-409C-AD65-2E8F04A7E112 Q28385940-54CC8E1D-3756-4FDB-8B18-4118C698CF2A Q33729693-EBFF7EB1-1E3C-4479-A674-12FE4BEFC916 Q35911314-16E8D45F-E874-4128-8B9F-368895B56217 Q36378426-F5D14E3A-B9D6-4F3C-ADB4-686C46F45668 Q36962382-3110857F-25CC-4DA7-901C-AB73E9DBF46A Q37437582-5C327B99-856E-43BB-96FF-F5807429ED24 Q37596033-9B212EE4-20EA-4303-97BC-027EB13B7C83 Q37687613-A1438205-B4E1-480B-85CB-D6FB0514B1FA Q38262833-DC72C8A6-1DE1-4A6E-B50A-372C56D7D6D4 Q38759188-3A46767B-354D-49B7-AB7E-06D52A0A0ED1 Q38787584-B29DDDFE-9FC4-412E-96F7-ECD446758414 Q38838144-6E23E95C-E1A8-48C2-83E1-D6BA8F7430D8 Q38903424-E0A3CF5A-3DE1-43BB-B740-22AE5A9DE467 Q40560920-2E2F6901-7A9A-4B42-8834-F58A91401129 Q40603254-98EAB35E-14BF-4747-A724-2FD94ECDA21C Q42376082-B8828232-1ECB-4433-9E7A-ACDBB277EA6C Q47108777-4666CB5F-BB2A-4E6E-B888-9D0211F5955A Q47916891-D3952DF7-1FC3-43A3-8D7D-283AE2CD4DD8 Q48157237-B316D421-23D6-4F57-A709-4C63027A2BB5 Q55443450-E1A1396C-D8B4-4706-9B7F-497AD17FBC1E Q58793758-CE285FA8-38BC-4DF2-85F5-A6DF7952C71E

P2860

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.

http://www.wikidata.org/entity/Q35833084

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.

@ast

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.

@en

type

label

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.

@ast

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.

@en

prefLabel

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.

@ast

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.

@en

P1433

Q35833084-B6C7C2E5-2B4D-477F-9DA5-2C046C00EDEE

P1476

Q35833084-01948CBB-85F9-4482-B202-C88DBD6051A5

P2093

Q35833084-653D34DB-BBC7-4785-8C3F-316FFEC52DE1

Q35833084-C388328A-29E5-438F-94FB-4BCC08DE0D93

Q35833084-C8CB0406-F9D7-4FF7-BC7E-E724549CE79F

Q35833084-C9A94FEF-793E-4D67-8B93-F7DB8AE89B6F

Q35833084-D7F49A0A-6499-43A8-8629-D7CAC0598E78

P2860

Q35833084-00BD768D-5559-4DE1-901F-8C06C198D1CD

Q35833084-0132CAE7-8DC4-4424-ABBC-E38CA298950F

Q35833084-05D3B341-9E8B-40D8-9C93-ECC3971F22EF

Q35833084-070D9C86-70E1-4CB3-BA8C-6D08B7C6454C

Q35833084-073B2919-923E-40B3-98A7-5B3E9CA31945

Q35833084-07B54CC3-5230-4FD2-BCE6-27923E7BDAC7

Q35833084-08BE38DF-6C10-435F-BC50-B8A492D39BFE

Q35833084-0F764CDA-0A73-4EE4-88C8-23AAE615C79E

Q35833084-1CA3F4F8-B54C-4D7A-8B5B-53CC6E2934E3

Q35833084-25815233-0032-4925-8D04-C3EA974A3D64

P304

Q35833084-5B33F2E6-26EA-4C4F-8A70-45654636FA2B

P31

Q35833084-3E919569-EA18-44D9-928D-F3E59ED62386

P356

Q35833084-155215DE-3BCA-45F4-85B4-ED53D92228BC

P407

Q35833084-31607FEE-7814-465A-854B-FED7F28F7CDC

P433

Q35833084-63FC064E-3B1A-48DA-9EFA-6EBD638451B7

P478

Q35833084-CA036819-1CA7-4C80-9198-B8372BA981D7

P50

Q35833084-57AEBADF-9DD0-48C0-A796-499D8E845D99

Q35833084-5DACAE18-4062-4BBD-9BCB-4179553E2163

P577

Q35833084-0FB8D29F-89E0-4828-A406-46508CC3D2E0

P5875

Q35833084-5EEC5C2E-0D08-4496-A116-820BCD71D842

P698

Q35833084-C36C1357-906F-42E7-883A-3075E3246DA6

P921

Q35833084-DE3245FF-BE52-45C2-85E9-3270B85D730E

P932

Q35833084-A6CAA7BD-5A11-4923-99AB-C6886B8AFA77

P356

ONCOTARGET.3329

P1433

P1476

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences

@en

P2093

Astrid Weyerbrock

http://www.w3.org/2001/XMLSchema#string

Barbara Heidenreich

http://www.w3.org/2001/XMLSchema#string

Florian Volz

http://www.w3.org/2001/XMLSchema#string

Kari Hemminki

http://www.w3.org/2001/XMLSchema#string

P Sivaramakrishna Rachakonda

http://www.w3.org/2001/XMLSchema#string

P2860

The 2007 WHO classification of tumours of the central nervous system

IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma

IDH mutations in tumorigenesis and their potential role as novel therapeutic targets.

TERT promoter mutations in primary and secondary glioblastomas.

The epidemiology of glioma in adults: a "state of the science" review

Genetics in glioma: lessons learned from genome-wide association studies

TERT promoter mutations: a novel independent prognostic factor in primary glioblastomas

Highly recurrent TERT promoter mutations in human melanoma

TERT promoter mutations in familial and sporadic melanoma

CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.

P304

10617-10633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.3329

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Md Ismail Hosen

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273454546

http://www.w3.org/2001/XMLSchema#string

P698

25797251

http://www.w3.org/2001/XMLSchema#string

P921

telomere length

P932

4496380

http://www.w3.org/2001/XMLSchema#string